These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 11703329

  • 1. Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity.
    Naumann R, Mohm J, Reuner U, Kroschinsky F, Rautenstrauss B, Ehninger G.
    Br J Haematol; 2001 Nov; 115(2):323-5. PubMed ID: 11703329
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Low dose vincristine-induced severe polyneuropathy in a Hodgkin lymphoma patient: a case report (vincristine-induced severe polyneuropathy).
    Cil T, Altintas A, Tamam Y, Battaloğlu E, Isikdogan A.
    J Pediatr Hematol Oncol; 2009 Oct; 31(10):787-9. PubMed ID: 19770686
    [Abstract] [Full Text] [Related]

  • 5. Vincristine neuropathy: neurophysiological and genetic studies in a case of Wilms tumor.
    Schiavetti A, Frascarelli M, Uccini S, Novelli A.
    Pediatr Blood Cancer; 2004 Oct; 43(5):606-9. PubMed ID: 15382281
    [Abstract] [Full Text] [Related]

  • 6. Vincristine neurotoxicity in the presence of hereditary neuropathy.
    Trobaugh-Lotrario AD, Smith AA, Odom LF.
    Med Pediatr Oncol; 2003 Jan; 40(1):39-43. PubMed ID: 12426685
    [No Abstract] [Full Text] [Related]

  • 7. Vincristine treatment revealing asymptomatic hereditary motor sensory neuropathy type 1A.
    Mercuri E, Poulton J, Buck J, Broadbent V, Bamford M, Jungbluth H, Manzur AY, Muntoni F.
    Arch Dis Child; 1999 Nov; 81(5):442-3. PubMed ID: 10519723
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Severe vincristine-induced polyneuropathy in a teenager with anaplastic medulloblastoma and undiagnosed Charcot-Marie-Tooth disease.
    Aghajan Y, Yoon JM, Crawford JR.
    BMJ Case Rep; 2017 Apr 24; 2017():. PubMed ID: 28438772
    [Abstract] [Full Text] [Related]

  • 11. Hereditary neuropathy with liability to pressure palsies emerging during vincristine treatment.
    Kalfakis N, Panas M, Karadima G, Floroskufi P, Kokolakis N, Vassilopoulos D.
    Neurology; 2002 Nov 12; 59(9):1470-1. PubMed ID: 12427913
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Severe neurotoxicities in a case of Charcot-Marie-Tooth disease type 2 caused by vincristine for acute lymphoblastic leukemia.
    Nishikawa T, Kawakami K, Kumamoto T, Tonooka S, Abe A, Hayasaka K, Okamoto Y, Kawano Y.
    J Pediatr Hematol Oncol; 2008 Jul 12; 30(7):519-21. PubMed ID: 18797198
    [Abstract] [Full Text] [Related]

  • 14. [Acute vincristine neurotoxicity in a non-Hodgkin's lymphoma patient with Charcot-Marie-Tooth disease].
    Uno S, Katayama K, Dobashi N, Hirano A, Ogihara A, Yamazaki H, Usui N, Kobayashi T, Inoue K, Kuraishi Y.
    Rinsho Ketsueki; 1999 May 12; 40(5):414-9. PubMed ID: 10390891
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Charcot-Marie-Tooth disease disclosed by a treatment with vincristine in familial Hodgkin's disease].
    Geny C, Gaio JM, Mallaret M, Goy A, Reymond F, Pegourie B, Yulis J, Perret JE.
    Ann Med Interne (Paris); 1990 May 12; 141(8):709-10. PubMed ID: 2091516
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Severe vincristine neuropathy in Charcot-Marie-Tooth disease type 1A.
    Graf WD, Chance PF, Lensch MW, Eng LJ, Lipe HP, Bird TD.
    Cancer; 1996 Apr 01; 77(7):1356-62. PubMed ID: 8608515
    [Abstract] [Full Text] [Related]

  • 20. Vincristine-induced fatal neuropathy in non-Hodgkin's lymphoma.
    Tarlaci S.
    Neurotoxicology; 2008 Jul 01; 29(4):748-9. PubMed ID: 18754106
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.